Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.
D000328:Adult; D000367:Age Factors; D001792:Blood Platelets / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004357:Drug Synergism; D005032:Ethylestrenol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000517:prevention & control; D010629:Phenformin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011188:Potassium / Q000378:metabolism; D012008:Recurrence; D013997:Time Factors
D005340:Fibrinogen; D002784:Cholesterol; D005032:Ethylestrenol; D010629:Phenformin; D011188:Potassium